Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Tranexamic acid reduces skin aging more in female mice.

The sensor accurately measures thallium ions in solutions with high selectivity.

Optimized liposomes can improve drug delivery and effectiveness.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tetracycline reduces fat breakdown in hair lipids.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Tigason improved hair growth in a boy with monilethrix without side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hair restoration can cause severe seizures due to combined drug toxicity.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

The new nanoparticles could improve melanoma treatment by working better than current options.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Topical tacalcitol ointment can help improve symptoms of EFFC.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.